ÃÛÌÒAPP

Biography

After her training in paediatric haematology and oncology, Dr Lum underwent further training in paediatric immunology, haematopoietic stem cell transplant and cellular therapy in Manchester and ÃÛÌÒAPP.

She joined the Children’s Haematopoietic Stem Cell Transplantation Unit in ÃÛÌÒAPP in 2018. She completed her PhD in clinical and immunological outcome after paediatric stem cell transplantation for inborn errors of immunity.

Dr Lum’s long-term vision is to improve the transplant outcomes and long-term health status of children with rare disease, through clinical trials and multi-centre collaborative studies. Her research interests include personalized haematopoietic stem cell transplantation, graft manipulation, memory T cells and late effects. She has developed Haplo+4kids trial which is the first UK investigator-led controlled clinical trial in stem cell transplantation for inborn errors of immunity.

This trial encompasses optimizing haploidentical donor transplant strategy using memory T cells and pharmacokinetic study of conditioning regimen.  She is also developing personalized survivorship care pathway for children and young adults after transplant for inborn errors of immunity.

Research  

Dr Lum’s long-term vision is to improve the transplant outcomes and long-term health status of children with rare disease, through clinical trials and multi-centre collaborative studies.

Her research interests include personalized haematopoietic stem cell transplantation, graft manipulation, memory T cells and late effects. She has developed Haplo+4kids trial which is the first UK investigator-led controlled clinical trial in stem cell transplantation for inborn errors of immunity.

This trial encompasses optimizing haploidentical donor transplant strategy using memory T cells and pharmacokinetic study of conditioning regimen.  She is also developing personalized survivorship care pathway for children and young adults after transplant for inborn errors of immunity.